Summary
Antipsychotic drugs are used to treat agitation, aggression, and psychosis in dementia when alternative strategies have failed. Their use has been reduced because of concerns about safety and limited efficacy. Drawing on data that the NHS publishes on a monthly basis on patients registered with a dementia diagnosis in England, this article considers evidence of an increase in antipsychotic prescribing to people with dementia during the COVID-19 pandemic.
Antipsychotic prescribing to people with dementia during COVID-19 (November 2019)
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(20)30370-7/fulltext#articleInformation
1
reactions so far
0 Comments
Recommended Comments
There are no comments to display.
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now